Skip to main content
. 2020 Jun 23;144:110024. doi: 10.1016/j.mehy.2020.110024

Fig. 2.

Fig. 2

COVID-19 Pulmonary damage model demonstrating effects of loss of ACE2 expressing cells (ciliated respiratory epithelial cells and type 2 alveolar cells), and vascular effects of ACE2 deficiency with endothelial injury, vasoconstriction, thrombosis, and interstitial oedema.